에이프로젠
서울에서’ JP모건 코리아 컨퍼런스 열린다
연합뉴스2019.02.10 16:36
PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to attend to JP Morgan's Korea Conference 2019 (February 21-22).
전문가방송
연관검색종목 03.29 18:00 기준
0/1000 byte